OakChart

Quantum Cyber NV

QUCYHealthcare·Diagnostics & Research·USA·Micro·NASD·Nov 11 • 3:58 PM ET

0.62450.0000 (0.00%)
2026-11-12 10:31 CET
Market cap
54.47 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-16.10 USD m
Free cash flow, TTM
-10.03 USD m
EPS diluted, TTM
-1.08
P/E
-
Compare

Price

QUCY against its 20, 50 and 200-day averages
2050200
Patternshover a marker to name it
Sales mean, own scale0–100
RS 9Sales 0.41Price0.412.004.00267.7M535.3MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26QUCYclose 0.6220-day 0.8750-day 1.15200-day 1.190.6252w high52w low

87.3% under the 52-week high of 4.93 on 15 May 2026. 52-week low 0.30 on 12 May 2026. Last 15 sessions, 86.1% high to low

the line is the 50-bar volume average

Profile

QUCY
52-week range, 7% of the way up
0.304.93

Quantum Cyber NV engages in assembling an artificial intelligence (AI)-powered, quantum-accelerated system-of-systems autonomous defense platform. It integrates drone warfare, counter-UAS, autonomous naval mine countermeasures, EMP shielding, anti-drone ammunition, command-and-control, and quantum antenna applications. The company was founded on March 8, 2021 and is headquartered in West Palm Beach, FL.

Employees13
IPONov 05, 2021
Beta2.44
ATR, 14d0.09
Rel volume0.00
Short float3.00%
Insider own69.87%
Inst own0.27%

Snapshot

6 groups

Valuation

Index-
Market Cap54.47M
Enterprise Value41.32M
Income-
Sales-
Book/sh0.81
Cash/sh0.15
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees13
IPONov 05, 2021

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B0.77
P/C4.07
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio5.56
Current Ratio5.56
Debt/Eq0.01
LT Debt/Eq0.00
Option/ShortNo / Yes

Earnings

EPS (ttm)-
EPS next Y-0.49
EPS next Q-0.08
EPS this Y-
EPS next Y-
EPS next 5Y79.59%
EPS past 3/5Y66.90% 8.38%
Sales past 3/5Y0.45% 1.70%
EPS Y/Y TTM11.95%
Sales Y/Y TTM-
EPS Q/Q97.59%
Sales Q/Q-100.00%
Earnings-
EPS/Sales Surpr.- -58.95%

Ownership

Insider Own69.87%
Insider Trans0.00%
Inst Own0.27%
Inst Trans-11.85%
ROA-
ROE-
ROIC-
Gross Margin-
Oper. Margin-
Profit Margin-
SMA20-28.39%
SMA50-45.81%
SMA200-47.54%
Trades-

Technical

Shs Outstand87.22M
Shs Float26.28M
Short Float3.00%
Short Ratio1.32
Short Interest0.79M
52W High4.93 -87.33%
52W Low0.30 108.17%
Volatility13.59% 10.42%
ATR (14)0.09
RSI (14)26.31
Beta2.44
Rel Volume0.00
Avg Volume597.65K
Volume0

Performance

Perf Week-15.95%
Perf Month-44.24%
Perf Quarter-56.02%
Perf Half Y-53.40%
Perf YTD-44.24%
Perf Year-51.96%
Perf 3Y-99.30%
Perf 5Y-99.83%
Perf 10Y-
Recom1.00
Target Price9.00
Prev Close0.62
Price0.62
Change %0.00%

Analyst ratings

latest 4 of 4
DateActionAnalystRating changeTargetImplied
Feb 14, 2025InitiatedMMaxim GroupBuy$14+2,141.8%
Nov 25, 2024DowngradeHH.C. WainwrightBuy → Neutral
Nov 21, 2023DowngradeCCantor FitzgeraldOverweight → Neutral
Jun 21, 2022InitiatedHH.C. WainwrightBuy$25+3,903.2%

Peers

Mkt cap
TickerCompanyMkt cap
IMDXInsight Molecular Diagnostics Inc78.21M
ARQQArqit Quantum Inc271.30M
QNCQuantum eMotion Corp221.56M
LAESSEALSQ Corp325.54M
UMACUnusual Machines Inc656.68M
IONQIonQ Inc14.37B
INFQInfleqtion Inc2.07B
QBTSD-Wave Quantum Inc3.96B
RGTIRigetti Computing Inc3.78B
XNDUXanadu Quantum Technologies Ltd800.55M

Insider trading

2 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
BAECHLER GUIDOOfficerMay 22 '26Proposed Sale3.77240,000904,800May 22 12:32 PM
BAECHLER GUIDOPolicy-Making OfficerMay 15 '26Proposed Sale3.46200,000692,000May 18 04:28 PM

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2025S22026-04-14-1.010-1.010-1.0100.670.671
2025S12025-09-03-2.650--2.6540.200.50-
2024Q32024-10-30-4.400--0.30--
2024S12024-10-21-19.600--2.6500.52--
2024Q12024-04-09-11.468--0.25--
2023Q32023-11-16-15.600-18.932-15.7810.180.333
2023Q22023-08-15-22.400-16.800-22.1290.250.283
2023Q12023-05-16-18.000-19.600-17.8670.250.273
2022Q42023-04-10-31.868--0.23-2
2022Q32022-11-02-17.200-15.200-0.200.201
2022Q22022-07-12-18.400-18.400-0.150.151
2022Q12022-06-17-19.600--0.11--
2025Q1---2.800--0.301
2025Q2---2.400--0.451
2025Q3---2.000--0.401
2025Q4---2.000--0.501

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2022FY-74.800-73.600-74.5540.510.57
2023FY-64.533-67.600-64.7580.900.94
2024FY-22.360-10.840-10.8400.891.05
2025FY-2.860-2.860-2.7030.870.87
2026FY--0.030--0.92
2027FY--0.030---
2028FY--0.030---
2029FY--0.040---
2030FY--0.040---

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026S1S2026-04-141000.410.410.41
2026S1S2025-12-231000.410.410.41
2026S1S2025-10-091010.410.410.41
2026S1S2025-09-031000.520.520.52
2026S1S2025-05-171000.520.520.52
2026S1S2025-05-161000.520.520.52
2026S1S2025-05-151000.520.520.52
2026S1S2025-05-141000.520.520.52
2026S1S2025-05-131000.520.520.52
2026S1S2025-05-121000.520.520.52
2026S1S2025-05-111000.520.520.52
2026S1S2025-05-101000.520.520.52
2026S1S2025-05-091000.520.520.52
2026S1S2025-05-081000.520.520.52

Estimate history

EPS, annual-4.187-64.847-74.554-64.758-21.912-2.703
Period202020212022202320242025
EPS, quarterly-0.133-17.867-22.129-15.781-0.431
PeriodQ1 '21Q1 '23Q2 '23Q3 '23Q1 '26
Sales, annual0.4940.5770.530.8950.8940.537
Period202020212022202320242025
Sales, quarterly00.250.2490.1820
PeriodQ1 '21Q1 '23Q2 '23Q3 '23Q1 '26
Shares, annual0.140.30.3660.5292.3199.7812.515
Period202020212022202320242025MRQ
Shares, quarterly0.30.3710.3660.41912.515
PeriodQ1 '21Q1 '23Q2 '23Q3 '23Q1 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Total Revenue0.000.540.890.900.530.580.49
Cost of Goods Sold Incl. D&A0.000.761.021.250.690.540.46
Gross Profit0.00-0.23-0.12-0.36-0.160.040.03
Selling, General and Administrative Excl. Other12.3513.2718.3726.2926.439.900.80
Research and Development4.584.395.209.073.550.470.31
Other Operating Expense0.000.000.000.000.000.000.00
Operating Income-12.35-13.50-18.50-26.64-26.59-9.86-0.77
Interest Expense0.020.370.950.250.210.200.18
Unusual Expense0.002.622.33-0.710.002.02-0.01
Net Income Before Taxes-12.56-16.21-21.60-26.30-26.39-11.69-0.59
Income Taxes0.000.000.000.000.000.000.00
Consolidated Net Income-12.56-16.21-21.60-26.30-26.39-11.69-0.59
Net Income From Continuing Operations-12.56-16.21-21.60-26.30-26.39-11.69-0.59
Net Income-16.10-16.21-21.60-26.30-26.39-11.69-0.59
EPS (Recurring)-1.08-2.40-20.26-65.98-74.55-57.00-4.23
EPS (Basic, Before Extraordinaries)-1.08-2.70-21.91-64.76-74.55-64.85-4.19
EPS (Diluted)-1.08-2.70-21.91-64.76-74.55-64.85-4.19
EBITDA-12.30-12.88-17.80-25.61-26.13-9.65-0.61
Non-Operating Income (Expense)-0.180.280.17-0.110.410.390.35
Other After Tax Adjustments-0.000.000.000.000.000.00
Stock Option Compensation Expense0.551.990.693.00---
Price To Sales Ratio-12.514.7621.04189.70129.77-
Gross Margin--42.07-13.62-39.84-30.016.526.22
Operating Margin--2,513.37-2,068.93-2,975.47-5,017.97-1,708.60-155.22
Net Margin--3,018.31-2,415.99-2,936.50-4,979.90-2,024.79-118.91
Shares Outstanding24.939.782.320.530.370.300.14
Market Capitalization54.4754.478.6519.43102.83124.78126.83

Income statement, quarterly

Currency USD, millions
Metric2026S12025S12022S1
Total Revenue0.000.29-0.24
Cost of Goods Sold Incl. D&A0.000.60-0.22
Gross Profit0.00-0.31-0.02
Selling, General and Administrative Excl. Other12.357.78-12.64
Research and Development4.582.77-0.89
Other Operating Expense0.00---
Operating Income-12.35-8.09--12.62
Interest Expense0.020.22-0.08
Unusual Expense0.00-0.02-0.00
Net Income Before Taxes-12.56-8.34--12.60
Income Taxes0.000.00-0.00
Consolidated Net Income-12.56-8.34--12.60
Net Income From Continuing Operations-12.56-8.34--12.60
Net Income-16.10-8.34--12.60
EPS (Recurring)-1.08-2.66--36.47
EPS (Basic, Before Extraordinaries)-1.08-2.65--36.47
EPS (Diluted)-1.08-2.65--36.47
EBITDA-12.30-7.59--12.52
Non-Operating Income (Expense)-0.18-0.06-0.09
Stock Option Compensation Expense0.551.00--
Gross Margin--108.24-7.40
Operating Margin--2,822.07--5,262.68
Net Margin--2,910.26--5,255.29
Shares Outstanding24.937.88-0.36
Market Capitalization54.475.38-133.97

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY
Cash & Short Term Investments0.896.247.0717.148.730.12
Short Term Receivables0.110.210.350.260.020.04
Inventories0.220.370.610.180.000.00
Other Current Assets0.621.200.940.800.860.02
Total Current Assets1.848.028.9818.389.610.19
Net Property, Plant & Equipment2.372.463.031.840.430.49
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets1.113.023.39-0.000.00
Other Assets0.000.000.000.020.000.00
Total Assets5.3313.5015.4120.2410.040.67
Short Term Debt Incl. Current Port. of LT Debt1.582.565.190.290.080.07
Accounts Payable0.431.342.361.330.830.25
Other Current Liabilities1.692.281.692.620.440.38
Total Current Liabilities3.696.189.244.241.350.70
Long Term Debt0.990.951.170.960.390.86
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.381.760.941.941.86
Total Liabilities4.697.5012.166.143.683.41
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity0.646.003.2514.106.36-2.74
Total Shareholders Equity0.646.003.2514.106.36-2.74
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity0.646.003.2514.106.36-2.74
Total Liabilities & Stockholders Equity5.3313.5015.4120.2410.040.67
Book Value Per Share0.072.596.1438.5421.19-19.56
Tangible Book Value Per Share-0.051.29-0.2738.5421.19-19.56
Full-Time Employees132671643131
Price to Book Ratio0.770.705.634.33561.44570.63
Return on Assets-174.63-149.42-147.52-174.28-218.22-
Return on Equity-484.76-467.15-303.20-257.98-645.93-
Return on Invested Capital-992.04-311.08-595.61-175.27-173.21-
Quick Ratio0.441.240.914.297.110.27
Current Ratio0.501.300.974.337.110.27

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY
Net Income-16.10-16.21-21.60-26.30-26.39-11.69-0.59
Depreciation0.060.620.701.030.460.210.15
Other Funds (Non Cash)7.506.253.653.399.778.40-0.09
Funds from Operations-8.54-9.35-17.25-21.87-16.16-3.08-0.53
Extraordinary Item0.000.000.000.000.000.000.00
Changes in Working Capital-1.36-1.63-0.07-0.061.39-0.140.06
Cash from Operating Activities-9.90-10.98-17.33-21.94-14.77-3.22-0.47
Capital Expenditures-0.99-1.05-0.25-1.90-0.66-0.02-0.01
Net Assets From Acquisitions0.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses1.250.020.020.000.000.000.00
Purchase or Sale of Investments0.000.000.030.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.030.000.000.000.00
Other Uses0.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.001.220.00
Cash from Investing Activities0.26-1.03-0.20-1.90-0.661.20-0.01
Cash Dividends Paid0.000.000.000.000.000.000.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.00
Change in Capital Stock23.328.2513.766.3924.2510.430.00
Repurchase of Common Pref Stock0.000.000.000.000.000.000.00
Sale of Common Pref Stock23.328.2513.766.3924.2510.430.00
Proceedsfrom Stock Options8.098.2513.766.3924.2510.430.00
Issuance or Reduction of Debt, Net-1.09-1.493.039.02-0.11-0.000.04
Change in Long Term Debt0.00-0.000.00---
Issuance of Long Term Debt0.00-0.000.00---
Reduction of Long Term Debt0.00-0.000.00---
Net Financing Active Other Cash Flow0.000.000.00-0.930.000.240.40
Other Financing Activities Uses0.000.000.00-0.930.000.000.00
Cash from Financing Activities22.236.7616.7914.2323.9410.610.40
Exchange Rate Effect-0.03-0.10-0.10-0.46-0.100.010.00
Net Change in Cash12.57-5.35-0.84-10.078.418.60-0.08
Free Cash Flow-10.03-10.98-17.43-23.14-15.43-3.24-0.48
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026S12025S12022S1
Cash & Short Term Investments13.381.91-26.01
Short Term Receivables0.000.20-0.33
Inventories0.000.50-0.04
Other Current Assets3.320.47-0.42
Total Current Assets16.693.09-26.80
Net Property, Plant & Equipment0.142.71-0.81
Total Investments and Advances0.000.00-0.00
Intangible Assets6.544.01--
Other Assets0.000.00-0.01
Total Assets23.379.80-27.62
Short Term Debt Incl. Current Port. of LT Debt0.171.99-0.11
Accounts Payable0.811.79-0.61
Other Current Liabilities2.032.21-1.75
Total Current Liabilities3.005.99-2.47
Long Term Debt0.001.10-0.48
Other Liabilities0.000.19-0.89
Total Liabilities3.007.28-3.84
Non-Equity Reserves0.000.00-0.00
Preferred Stock - Carrying Value0.060.00-0.00
Common Equity20.302.52-23.77
Total Shareholders Equity20.362.52-23.77
Accumulated Minority Interest0.000.00-0.00
Total Equity20.362.52-23.77
Total Liabilities & Stockholders Equity23.379.80-27.62
Book Value Per Share0.810.32-65.65
Tangible Book Value Per Share0.55-0.19-65.65
Price to Book Ratio0.770.23-5.64
Return on Invested Capital-79.06-230.34--51.98
Quick Ratio5.560.43-10.82
Current Ratio5.560.52-10.83

Cash flow, quarterly

Currency USD, millions
Metric2026S12025S12022S1
Net Income-16.10-8.34--12.60
Depreciation0.060.50-0.10
Other Funds (Non Cash)7.501.44-5.68
Funds from Operations-8.54-6.40--6.82
Extraordinary Item0.000.00-0.00
Changes in Working Capital-1.36-0.11-0.36
Cash from Operating Activities-9.90-6.52--6.46
Capital Expenditures-0.99-0.45--0.25
Net Assets From Acquisitions0.000.00-0.00
Sale of Fixed Assets and Businesses1.250.00-0.00
Purchase or Sale of Investments0.000.00-0.00
Purchase of Investments0.000.00-0.00
Sale Or Maturity of Investments0.000.00-0.00
Other Uses0.000.00-0.00
Other Sources0.000.00-0.00
Cash from Investing Activities0.26-0.45--0.25
Cash Dividends Paid0.000.00-0.00
Preferred Dividends (Cash Flow)-0.00-0.00
Change in Capital Stock23.323.53-24.25
Repurchase of Common Pref Stock0.000.00-0.00
Sale of Common Pref Stock23.323.53-24.25
Proceedsfrom Stock Options8.090.00-23.87
Issuance or Reduction of Debt, Net-1.09-0.65--0.11
Change in Long Term Debt0.00---
Issuance of Long Term Debt0.00---
Reduction of Long Term Debt0.00---
Net Financing Active Other Cash Flow0.000.00-0.00
Other Financing Activities Uses0.000.00-0.00
Cash from Financing Activities22.232.68-24.09
Exchange Rate Effect-0.03-0.03--0.10
Net Change in Cash12.57-4.32-17.28
Free Cash Flow-10.03-6.52--6.71

Revenue breakdown

Pharmaceutical Preparations2024: 893.99K 2025: 537.08K
Germany2024: 893.99K 2025: 537.08K

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-303.00%0.8M26.3M652.07K
2026-10-154.75%1.2M26.3M696.74K
2026-09-306.37%1.6M25.3M750.39K
2026-09-157.36%1.9M25.3M2.04M
2026-08-318.87%2.2M25.3M3.04M
2026-08-143.70%2.6M70.5M6.45M
2026-07-3112.00%2.6M21.4M19.11M
2026-07-1513.13%2.8M21.4M19.56M
2026-06-3016.35%3.4M20.6M19.27M
2026-06-159.83%1.9M19.5M17.75M
2026-05-298.05%1.5M18.9M16.96M
2026-05-1585.27%10.5M12.4M14.92M
2026-04-308.99%1.0M10.7M856.56K
2026-04-156.42%0.7M10.7M705.95K
2026-03-312.76%0.3M10.0M621.07K
2026-03-134.75%0.5M10.0M565.90K
2026-02-276.49%0.5M7.2M468.24K
2026-02-133.42%0.2M7.2M382.23K
2026-01-303.87%0.3M8.3M561.24K
2026-01-153.08%0.3M8.3M492.01K

Option chain

expiry 2026-11-12
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-168-KCurrent report2026-10-12SEC
2026-10-098-KCurrent report2026-10-09SEC
2026-10-09424B5SEC
2026-09-258-K/A2026-07-15SEC
2026-09-258-KCurrent report2026-09-25SEC
2026-08-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-11SEC
2026-08-10SCHEDULE 13GSEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-05SEC
2026-08-07SCHEDULE 13D/ASEC
2026-08-064/A2026-07-22SEC
2026-08-064/A2026-07-22SEC
2026-08-064/A2026-07-22SEC
2026-08-064/A2026-07-22SEC
2026-08-064/A2026-07-22SEC
2026-08-054Statement of changes in beneficial ownership of securities2026-07-31SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-07-31SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-07-31SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-07-31SEC
2026-08-044Statement of changes in beneficial ownership of securities2026-07-31SEC
2026-07-248-KCurrent report2026-07-24SEC
2026-07-168-KCurrent report2026-07-15SEC
2026-07-093Initial statement of beneficial ownership of securities2026-07-01SEC
2026-07-074Statement of changes in beneficial ownership of securities2026-07-06SEC
2026-07-078-KCurrent report2026-07-01SEC
2026-07-018-KCurrent report2026-06-26SEC
2026-06-268-KCurrent report2026-06-22SEC
2026-06-15EFFECTEffectiveness filing by commission orderSEC
2026-06-158-KCurrent report2026-06-11SEC
2026-06-12CORRESPSEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
JANE STREET GROUP, LLC0.37%
Virtu Financial LLC0.18%
Steward Partners Investment Advisory, LLC0.09%
XTX Topco Ltd0.05%
MORGAN STANLEY0.05%
Journey Advisory Group, LLC0.04%
Integrated Advisors Network LLC0.02%
Tower Research Capital LLC0.02%
UBS Group AG0.01%
Prasad Wealth Partners, LLC0.01%

Funds

Fund% owned
Fidelity Nasdaq Composite Index Fund0.01%

OakChart. QUCY. Cached 15 minutes.